Using Artificial Tears With RESTASIS®

The benefits of using RESTASIS® Ophthalmic Emulsion will occur with continued use over time. While RESTASIS® begins to increase tear production, you can continue to use artificial tears for relief of dry eye symptoms. Over-the-counter eye care products for your various dry eye needs are available, including OPTIVE™ Lubricant Eye Drops.

Many RESTASIS® Ophthalmic Emulsion users may start to make more of their own tears within 1 month. One sign that your tear production may be increasing would be that you have less need to use artificial tears. Over the first 6 months of RESTASIS® treatment, your use of artificial tears is likely to decrease.

OPTIVE Moisterizing Dry Eye Solution

OPTIVE™ Lubricant Eye Drops

Use in conjunction with your RESTASIS® therapy.

OPTIVE™ relieves dry eyes two ways.
Its dual action formula lubricates and hydrates for longer-lasting comfort.*

  • Effectively treats Dry Eye symptoms
  • Makes eyes feel better longer*
  • Safely relieves and moisturizes
    *Longer lasting vs. Systane®.1

Visit www.optivesolutions.com for more information and valuable savings.

Systane® is a registered trademark of Alcon, Inc.

Reference

  1. Data on file.

 

Next: Find out how you can save money on your RESTASIS® prescription »

RESTASIS® Ophthalmic Emulsion helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using topical steroid drops or tear duct plugs.

Important Safety Information:

RESTASIS® Ophthalmic Emulsion should not be used by patients with active eye infections and has not been studied in patients with a history of herpes viral infections of the eye. The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

Please see product information for RESTASIS® Ophthalmic Emulsion.

Allergan, Inc.

© 2008 Allergan, Inc. All rights reserved | Privacy Statement | FAQs | Terms of Use | Site Map | Contact Us
This information is intended for residents of the United States. ® and ™ marks owned by Allergan, Inc.